<?xml version="1.0"?>
<rss version="2.0">
<channel>
<title>EIN News: India &amp; Pakistan Pharmaceuticals News</title>
<link>http://www.einnews.com/india-pakistan/newsfeed-india-pakistan-pharmaceuticals</link><description>Constantly updated news and information about world affairs.</description><item>
<title>Godrej group to foray into oil &amp; gas equipment biz: report</title>
<link>http://www.einnews.com/news.php?wid=180028868</link>
<pubDate>24 Jul 2008 10:35 GMT</pubDate>
<description>
...  into oil &amp; gas equipment biz: report India Infoline News Service / Mumbai Jul 24,  ...  project is pegged at around Rs1.5bn. The company has already acquired land at Dahej in  ...  refineries, petrochemicals, fertilisers, oil &amp; gas, chemicals, pharmaceuticals and power. ...
</description>
</item><item>
<title>Glaxo Deal Opens Way for Aspen to Grow</title>
<link>http://www.einnews.com/news.php?wid=180023141</link>
<pubDate>24 Jul 2008 09:36 GMT</pubDate>
<description>
...  clinched a licensing and distribution deal with pharmaceutical giant GlaxoSmithKline that will see its products  ...  distribution footprint,&quot; he said. Aspen already had business interests in SA, Australasia, India, East Africa, Brazil, Mexico and Venezuela, and  ...
</description>
</item><item>
<title>Halal Industry in the ME estimated to be worth Dhs73bn</title>
<link>http://www.einnews.com/news.php?wid=180022942</link>
<pubDate>24 Jul 2008 09:36 GMT</pubDate>
<description>
...  catering, hospitality, food and beverage, health and pharmaceuticals industries. &apos;The growth of the global Halal  ...  Brazil, Brunei, Bosnia, Canada, China, Egypt, France, India, Indonesia, Iran, Jordan, Netherlands, Pakistan, The Philippines, Turkey, Thailand, Malaysia, Singapore, KSA,  ...
</description>
</item><item>
<title>Thermo Fisher Scientific Reports Record 2008 Second Quarter Results</title>
<link>http://www.einnews.com/news.php?wid=180022440</link>
<pubDate>24 Jul 2008 09:35 GMT</pubDate>
<description>
...  strengthened analytical and environmental instrument capabilities in India, and expanded bioreagents portfolio for life sciences  ...  employees and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic  ...  effect of rapid changes in the healthcare industry. While we may elect to update forward-looking  ...
</description>
</item><item>
<title>Onco Therapies signs licensing and supply pact with GSK</title>
<link>http://www.einnews.com/news.php?wid=180020022</link>
<pubDate>24 Jul 2008 09:15 GMT</pubDate>
<description>
...  and supply agreement is for 95 emerging markets, excluding Sub-Saharan Africa and India. Under the deal, OTL will license intellectual  ...  intellectual property and supply finished dosage form pharmaceuticals to GSK. OTL will recover intellectual property  ...
</description>
</item><item>
<title>Take solutions charters new territory</title>
<link>http://www.einnews.com/news.php?wid=180016989</link>
<pubDate>24 Jul 2008 08:56 GMT</pubDate>
<description>
...  Solutions announced on Thursday that its worldwide business in regulatory document management and electronic submissions  ...  Indian market. Amongst others, key customers in India are Ajanta Pharma, Alembic Ltd., Alkem, Dabur, Emcure Pharmaceuticals, Marksans Pharma and Serum Institute. With e-submissions  ...
</description>
</item><item>
<title>Halal industry in the Middle East estimated to be worth in excess of AED 73 billion</title>
<link>http://www.einnews.com/news.php?wid=180016652</link>
<pubDate>24 Jul 2008 08:56 GMT</pubDate>
<description>
...  catering, hospitality, food and beverage, health and pharmaceuticals industries. The growth of the global Halal  ...  Brazil, Brunei, Bosnia, Canada, China, Egypt, France, India, Indonesia, Iran, Jordan, Netherlands, Pakistan, The Philippines, Turkey, Thailand, Malaysia, Singapore, KSA,  ...
</description>
</item><item>
<title>Developing markets drive global adspend growth</title>
<link>http://www.einnews.com/news.php?wid=180007119</link>
<pubDate>24 Jul 2008 07:36 GMT</pubDate>
<description>
...  billion (RM1.69 trillion) underpinned by strong developing markets in Asia-Pacific, Central and Eastern Europe, Latin  ...  Russia (+92.1%), Brazil (+79.6%), the UK (+22.8%), India (+52.2%), Japan (+5.7%), South Korea (+21.6%), South  ...  were transportation (+97%), industrial (+68%), government (+65%), pharmaceuticals (+62%) and media (+56%). Many local advertisers  ...
</description>
</item><item>
<title>Fitch affirms Jubilant Organosys ratings</title>
<link>http://www.einnews.com/news.php?wid=180007092</link>
<pubDate>24 Jul 2008 07:35 GMT</pubDate>
<description>
... India Infoline News Service / Mumbai Jul 24,  ...  company has expanded its presence in the pharmaceuticals business value chain through organic and inorganic  ...  industry, although its experience in the chemicals industry and its initiatives in moving up the  ...
</description>
</item><item>
<title>SHU announces India scholarships and joint ventures</title>
<link>http://www.einnews.com/news.php?wid=180003537</link>
<pubDate>24 Jul 2008 07:08 GMT</pubDate>
<description>
...  launch of the Sheffield Hallam University (SHU) India Office in July 2008, the University on  ...  designed looking at the needs of the industry. 89 per cent of SHU graduates get  ...  are popular with Indian students are physiotherapy, pharmaceutical analyses, information technology, computing and networking, hospitality  ...
</description>
</item><item>
<title>TAKE Solutions bags four new Indian clients</title>
<link>http://www.einnews.com/news.php?wid=180001412</link>
<pubDate>24 Jul 2008 06:56 GMT</pubDate>
<description>
... TAKE Solutions announced that its worldwide business in regulatory document management and electronic submissions  ...  Indian market. Amongst others, key customers in India are Ajanta Pharma, Alembic, Alkem, Dabur, Emcure Pharmaceuticals, Marksans Pharma and Serum Institute. With esubmissions  ...
</description>
</item><item>
<title>Glaxo deal opens way for Aspen to grow</title>
<link>http://www.einnews.com/news.php?wid=180000806</link>
<pubDate>24 Jul 2008 06:52 GMT</pubDate>
<description>
...  clinched a licensing and distribution deal with pharmaceutical giant GlaxoSmithKline that will see its products  ...  distribution footprint, he said. Aspen already had business interests in SA, Australasia, India, East Africa, Brazil, Mexico and Venezuela, and  ...
</description>
</item><item>
<title>THOMSON REUTERS PUBLISHES CMR INTL&apos;S 2008 PHARMA R&amp;D FACTBOOK</title>
<link>http://www.einnews.com/news.php?wid=179998764</link>
<pubDate>24 Jul 2008 06:32 GMT</pubDate>
<description>
...  below.) Thomson Reuters Publishes CMR International&apos;s 2008 Pharmaceutical R&amp;D Factbook, Now Available for the First  ...  rapidly increasing. In particular, generics manufacturers in India are having an increased impact. &quot;The R&amp;D  ...  information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical  ...
</description>
</item><item>
<title>Thomson Reuters Publishes CMR International&apos;s 2008 Pharmaceutical R&amp;D Factbook, Now Available for th</title>
<link>http://www.einnews.com/news.php?wid=179992691</link>
<pubDate>24 Jul 2008 05:37 GMT</pubDate>
<description>
... Thomson Reuters Publishes CMR International&apos;s 2008 Pharmaceutical R&amp;D Factbook, Now Available for the First  ...  rapidly increasing. In particular, generics manufacturers in India are having an increased impact. &quot;The R&amp;D  ...  information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical  ...
</description>
</item><item>
<title>Sigma-Aldrich (Nasdaq: SIAL) Reports 16.7% Gain in Q2 2008...</title>
<link>http://www.einnews.com/news.php?wid=179988144</link>
<pubDate>24 Jul 2008 04:34 GMT</pubDate>
<description>
...  growth in our primary focus markets of India, Brazil and China ranged from 10% to  ...  delivery at , but recent economic and industry conditions and discussions with customers have led  ...  spending by select customers for our custom pharmaceutical products. A carryover benefit in Q1 2008  ...
</description>
</item></channel>
</rss>
